Pre-Operative Hormone Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer: An Uncontrolled Phase IIb/III Trial to Assess Optimal Duration of Pre-Operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers.

Trial Profile

Pre-Operative Hormone Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer: An Uncontrolled Phase IIb/III Trial to Assess Optimal Duration of Pre-Operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 11 Feb 2011

At a glance

  • Drugs Letrozole (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 06 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top